MatthewThomasRondinaMD
Internal Medicine • Salt Lake City, UTHospital Medicine/Hospitalist
Assistant Professor, Internal Medicine, University of Utah School of Medicine
Dr. Rondina is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
VA SLC HCS
500 Foothill Drive
Salt Lake City, UT 84148Phone+1 801-582-1565Fax+1 801-581-8937
Education & Training
University of Utah HealthResidency, Internal Medicine, 2003 - 2006
University of Utah School of MedicineClass of 2003
Certifications & Licensure
UT State Medical License 2004 - 2026
MT State Medical License 2008 - 2012- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Clot Dissolving Treatment for Blood Clots in the Lungs Start of enrollment: 2008 May 01
- Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients Start of enrollment: 2005 Mar 01
Publications & Presentations
PubMed
- 112 citationsThe septic milieu triggers expression of spliced tissue factor mRNA in human plateletsMatthew T. Rondina, Hansjörg Schwertz, Estelle S. Harris, Bjoern F. Kraemer, Robert A. Campbell
Journal of Thrombosis and Haemostasis. 2011-04-01 - 91 citationsIn Vivo Platelet Activation in Critically Ill Patients With Primary 2009 Influenza A(H1N1)Matthew T. Rondina, BreAnna Brewster, Colin K. Grissom, Guy A. Zimmerman, Diana Kastendieck
Chest. 2012-06-01 - 219 citationsPlatelets as Cellular Effectors of Inflammation in Vascular DiseasesMatthew T. Rondina, Andrew S. Weyrich, Guy A. Zimmerman
Circulation Research. 2013-05-24
Journal Articles
- TLT-1 Is a Prognostic Indicator in ALI/ARDS and Prevents Tissue Damage in the Lungs in a Mouse ModelMatthew Rondina, MD, Blood
Abstracts/Posters
- Comparing the Risk of Complications for Second-Line Treatments of Immune Thrombocytopenia in Veterans: A U.S. National StudyMatthew T. Rondina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Biomarkers of Hemostatic Activation and Inflammation Are Associated with Altered Coagulation Parameters in Sepsis PatientsMatthew T. Rondina, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- PDK1 Governs Thromboxane Generation and Thrombosis in Platelets by Regulating Activation of Raf1 in the MAPK Pathway: ReplyMatthew Rondina, MD, Journal of Thrombosis and Haemostasis, Orlando, FL, 12/9/2019
Press Mentions
NASA Funds University of Utah Health Project on Biological Impacts of Space TravelMarch 26th, 2022- Joint 3i/U2M2 Project Grants Open Pathways for Infectious Disease ResearchApril 29th, 2021
- Remembering Guy Zimmerman, MDJune 13th, 2024
Grant Support
- The Regulation Of Inflammatory Gene Responses In AgingNational Institute On Aging2011
- Novel Platelet Functions In Sepsis And Venous ThromboembolismNational Heart, Lung, And Blood Institute2009–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
